John R Chamberlain, MD
Psychiatry · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 31 years
- University of California, San Diego School of Medicine, 1995
Offices
1 location · University of California San Francisco · 1,780 clinicians in this group
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chamberlain’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$56,349
Medicare paid this office $56,349 for 165 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 159 | $41,268 | $81 |
| Psychotherapy with evaluation and management visit, 30 minutes | 18 | $5,723 | $53 |
Who their Medicare patients are
165 Original Medicare patients in 2024. Average age 67 · Under 65 35% · Women 62% · Also on Medicaid 44% · Health risk score 1.88. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 63% · Chronic kidney disease 30% · Diabetes 21% · Coronary heart disease 16% · Cancer 13% · COPD 13% · Heart failure 10% · Dementia 9% · Atrial fibrillation 8% · Stroke 8%.
The office billed $394,505, Medicare allowed $74,916 and paid $56,349; for 746 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 165 | 746 | 67 | 1.88 | $394,505 | $56,349 |
| 2023 | 300 | 935 | 66 | 1.57 | $509,351 | $72,907 |
| 2022 | 281 | 1,156 | 66 | 1.51 | $589,161 | $85,881 |
| 2021 | 203 | 889 | 67 | 1.47 | $428,335 | $67,001 |
| 2020 | 229 | 828 | 63 | 1.45 | $430,166 | $56,631 |
| 2019 | 160 | 459 | 62 | 1.43 | $248,658 | $32,486 |
| 2018 | 179 | 487 | 60 | 1.37 | $259,706 | $33,438 |
| 2017 | 124 | 322 | 59 | 1.46 | $167,487 | $23,525 |
| 2016 | 126 | 442 | 58 | 1.42 | $196,574 | $29,440 |
| 2015 | 85 | 264 | 59 | 1.47 | $98,811 | $16,135 |
| 2014 | 27 | 82 | 54 | 1.81 | $28,102 | $5,426 |
| 2013 | 21 | 101 | 56 | 1.29 | $31,486 | $4,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 275 | $58,745 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $6,335 | $53 |
| Psychiatric diagnostic evaluation with medical services | 17 | $2,231 | $131 |
| Short return visit (20+ min) | 18 | $1,408 | $44 |
2022: 5 services
| Return visit (30+ min) | 238 | $60,614 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 37 | $9,696 | $54 |
| Short return visit (20+ min) | 47 | $6,989 | $57 |
| Psychiatric diagnostic evaluation with medical services | 15 | $2,278 | $152 |
| Telephone medical discussion with physician, 5-10 minutes | 32 | $1,279 | $26 |
2021: 5 services
| Return visit (30+ min) | 166 | $41,216 | $87 |
| Psychotherapy with evaluation and management visit, 30 minutes | 32 | $7,471 | $55 |
| Short return visit (20+ min) | 36 | $6,928 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,636 | $68 |
| Telephone medical discussion with physician, 5-10 minutes | 33 | $1,298 | $29 |
2020: 6 services
| Return visit (30+ min) | 191 | $35,042 | $68 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $5,818 | $55 |
| Psychiatric diagnostic evaluation with medical services | 26 | $3,191 | $123 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,429 | $71 |
| Telephone medical discussion with physician, 5-10 minutes | 28 | $859 | $23 |
| Short return visit (20+ min) | 13 | $743 | $46 |
2019: 3 services
| Return visit (30+ min) | 143 | $21,782 | $69 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $3,993 | $56 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,373 | $125 |
2018: 2 services
| Return visit (30+ min) | 158 | $23,066 | $66 |
| Short return visit (20+ min) | 15 | $730 | $38 |
2017: 1 service
| Return visit (30+ min) | 95 | $12,316 | $66 |
2016: 2 services
| Return visit (30+ min) | 67 | $8,015 | $65 |
| Short return visit (20+ min) | 39 | $2,569 | $37 |
2015: 2 services
| Short return visit (20+ min) | 54 | $4,995 | $45 |
| Short return visit (20+ min) | 14 | $4,209 | $69 |
2014: 2 services
| Psychiatric diagnostic evaluation with medical services | 12 | $1,451 | $121 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $1,185 | $35 |
Medicaid work
$2,114 in 2024
Medicaid paid $2,114 for 70 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 70 | $2,114 |
| 2024 | 70 | 1 | 13 | $2,114 |
| 2023 | 68 | 1 | 17 | $3,043 |
| 2022 | 43 | 2 | 18 | $106 |
| 2020 | 15 | 1 | 13 | $321 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 68 | $3,043 |
2022
| Return visit (30+ min) | 13 | $106 |
| Hospital outpatient clinic visit for assessment and management of a patient | 30 | $0 |
2020
| Return visit (30+ min) | 15 | $321 |
Drugs they prescribed that Part D paid
$3,538
Pharmacies billed $3,538 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 98) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
96 generic and fewer than 11 brand-name prescriptions · $3,538 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mirtazapine | 14 | $139 | $10 |
| Diazepam | 13 | $35 | $3 |
Year by year
| 2024 | 98 | 31 | 0% (0) | None | $3,538 |
| 2023 | 94 | 24 | 0% (0) | 14% | $6,370 |
| 2022 | 58 | 26 | 0% (0) | None | $7,830 |
| 2021 | 682 | 122 | 0% (0) | 3% | $34,629 |
| 2020 | 1,138 | 185 | 0% (0) | None | $103,707 |
| 2019 | 806 | 167 | 0% (0) | 7% | $69,034 |
| 2018 | 941 | 163 | 0% (0) | 7% | $74,122 |
| 2017 | 494 | 91 | 0% (0) | 4% | $32,309 |
| 2016 | 479 | 69 | 0% (0) | 6% | $22,390 |
| 2015 | 241 | 34 | 0% (0) | 7% | $12,742 |
| 2014 | 143 | 15 | None | 8% | $11,053 |
| 2013 | 177 | 17 | 0% (0) | 14% | $11,301 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Duloxetine | 16 | $448 | $28 |
| Mirtazapine | 14 | $188 | $13 |
2021: 19 drugs
| Bupropion Xl | 58 | $2,635 | $45 |
| Mirtazapine | 78 | $2,593 | $33 |
| Duloxetine | 62 | $2,030 | $33 |
| Quetiapine | 28 | $1,646 | $59 |
| Naltrexone | 16 | $1,328 | $83 |
| Doxepin | 15 | $1,289 | $86 |
| Dextroamphetamine-Amphet Er | 11 | $1,096 | $100 |
| Venlafaxine Hcl Er | 16 | $782 | $49 |
| Dextroamphetamine-Amphetamine | 12 | $682 | $57 |
| Gabapentin | 48 | $502 | $10 |
| Sertraline | 39 | $407 | $10 |
| Hydroxyzine | 15 | $380 | $25 |
| Trazodone | 23 | $361 | $16 |
| Propranolol | 14 | $287 | $21 |
| Risperidone | 27 | $268 | $10 |
| Lamotrigine | 38 | $260 | $7 |
| Lithium Carbonate | 20 | $251 | $13 |
| Buspirone | 17 | $197 | $12 |
| Escitalopram | 23 | $179 | $8 |
2020: 30 drugs
| Bupropion Xl | 102 | $5,785 | $57 |
| Trintellix | 14 | $5,601 | $400 |
| Duloxetine | 84 | $5,580 | $66 |
| Venlafaxine Hcl Er | 41 | $4,139 | $101 |
| Ziprasidone | 16 | $1,932 | $121 |
| Mirtazapine | 57 | $1,836 | $32 |
| Aripiprazole | 33 | $1,593 | $48 |
| Quetiapine | 40 | $1,549 | $39 |
| Trazodone | 70 | $1,511 | $22 |
| Hydroxyzine | 25 | $1,121 | $45 |
| Gabapentin | 65 | $937 | $14 |
| Dextroamphetamine-Amphetamine | 22 | $935 | $42 |
| Sertraline | 75 | $857 | $11 |
| Modafinil | 11 | $780 | $71 |
| Naltrexone | 16 | $736 | $46 |
| Oxcarbazepine | 11 | $668 | $61 |
| Liothyronine | 18 | $659 | $37 |
| Dextroamphetamine-Amphet Er | 15 | $642 | $43 |
| Escitalopram | 54 | $522 | $10 |
| Lamotrigine | 29 | $471 | $16 |
| Prazosin | 12 | $452 | $38 |
| Buspirone | 24 | $419 | $17 |
| Risperidone | 22 | $406 | $18 |
| Lithium Carbonate | 27 | $344 | $13 |
| Fluoxetine | 16 | $285 | $18 |
| Paroxetine | 11 | $284 | $26 |
| Olanzapine | 14 | $153 | $11 |
| Hydroxyzine Pamoate | 11 | $125 | $11 |
| Diazepam | 11 | $64 | $6 |
| Clonazepam | 13 | $48 | $4 |
2019: 21 drugs
| Aripiprazole | 38 | $4,971 | $131 |
| Bupropion Xl | 84 | $4,318 | $51 |
| Venlafaxine Hcl Er | 35 | $3,566 | $102 |
| Viibryd | 11 | $3,458 | $314 |
| Duloxetine | 63 | $3,436 | $55 |
| Quetiapine | 30 | $813 | $27 |
| Trazodone | 41 | $807 | $20 |
| Escitalopram | 49 | $765 | $16 |
| Divalproex Sodium Er | 11 | $761 | $69 |
| Mirtazapine | 33 | $746 | $23 |
| Gabapentin | 36 | $732 | $20 |
| Lamotrigine | 43 | $645 | $15 |
| Dextroamphetamine-Amphetamine | 12 | $563 | $47 |
| Fluoxetine | 25 | $530 | $21 |
| Buspirone | 12 | $525 | $44 |
| Hydroxyzine | 18 | $502 | $28 |
| Haloperidol Decanoate | 13 | $335 | $26 |
| Sertraline | 31 | $301 | $10 |
| Bupropion | 13 | $295 | $23 |
| Lithium Carbonate | 16 | $218 | $14 |
| Olanzapine | 21 | $180 | $9 |
2018: 22 drugs
| Aripiprazole | 40 | $4,782 | $120 |
| Bupropion Xl | 82 | $4,622 | $56 |
| Viibryd | 14 | $4,146 | $296 |
| Duloxetine | 64 | $2,960 | $46 |
| Divalproex Sodium Er | 16 | $2,723 | $170 |
| Trazodone | 100 | $2,320 | $23 |
| Venlafaxine Hcl Er | 25 | $1,026 | $41 |
| Quetiapine | 45 | $1,001 | $22 |
| Fluoxetine | 21 | $771 | $37 |
| Mirtazapine | 44 | $703 | $16 |
| Lithium Carbonate Er | 26 | $699 | $27 |
| Buspirone | 15 | $673 | $45 |
| Lamotrigine | 65 | $625 | $10 |
| Gabapentin | 19 | $609 | $32 |
| Bupropion | 23 | $463 | $20 |
| Sertraline | 59 | $444 | $8 |
| Haloperidol Decanoate | 11 | $410 | $37 |
| Prazosin | 12 | $400 | $33 |
| Escitalopram | 31 | $372 | $12 |
| Hydroxyzine | 22 | $265 | $12 |
| Lithium Carbonate | 14 | $127 | $9 |
| Olanzapine | 13 | $105 | $8 |
2017: 12 drugs
| Duloxetine | 31 | $2,085 | $67 |
| Bupropion Xl | 34 | $1,840 | $54 |
| Trazodone | 49 | $1,746 | $36 |
| Aripiprazole | 18 | $1,543 | $86 |
| Fluoxetine | 27 | $790 | $29 |
| Venlafaxine Hcl Er | 26 | $713 | $27 |
| Quetiapine | 24 | $547 | $23 |
| Mirtazapine | 44 | $505 | $11 |
| Sertraline | 44 | $375 | $9 |
| Lamotrigine | 19 | $185 | $10 |
| Escitalopram | 20 | $182 | $9 |
| Topiramate | 12 | $110 | $9 |
2016: 15 drugs
| Duloxetine | 20 | $3,423 | $171 |
| Bupropion Xl | 18 | $956 | $53 |
| Venlafaxine Hcl Er | 46 | $865 | $19 |
| Mirtazapine | 55 | $817 | $15 |
| Quetiapine | 23 | $565 | $25 |
| Trazodone | 34 | $520 | $15 |
| Lithium Carbonate Er | 24 | $490 | $20 |
| Lamotrigine | 44 | $481 | $11 |
| Gabapentin | 20 | $355 | $18 |
| Sertraline | 20 | $249 | $12 |
| Escitalopram | 26 | $233 | $9 |
| Bupropion | 11 | $172 | $16 |
| Bupropion Hcl Sr | 12 | $147 | $12 |
| Topiramate | 12 | $119 | $10 |
| Propranolol | 13 | $107 | $8 |
2015: 7 drugs
| Venlafaxine Hcl Er | 37 | $936 | $25 |
| Lamotrigine | 24 | $302 | $13 |
| Lithium Carbonate Er | 15 | $300 | $20 |
| Trazodone | 25 | $224 | $9 |
| Topiramate | 13 | $126 | $10 |
| Sertraline | 11 | $118 | $11 |
| Clonazepam | 12 | $62 | $5 |
2014: 5 drugs
| Venlafaxine Hcl Er | 16 | $496 | $31 |
| Trazodone | 23 | $193 | $8 |
| Lamotrigine | 11 | $114 | $10 |
| Mirtazapine | 12 | $104 | $9 |
| Citalopram Hbr | 15 | $98 | $7 |
2013: 7 drugs
| Venlafaxine Hcl Er | 18 | $576 | $32 |
| Topiramate | 17 | $457 | $27 |
| Trazodone | 18 | $167 | $9 |
| Lamotrigine | 14 | $165 | $12 |
| Mirtazapine | 13 | $126 | $10 |
| Citalopram Hbr | 18 | $116 | $6 |
| Buspirone | 12 | $45 | $4 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114036480
- Licence
- CA A065086
- Trained
- University of California, San Diego School of Medicine, 1995 · 31 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084F0202X (2084F0202X); Psychiatry (2084P0800X)
- Mailing address
- 401 Parnassus Ave, Box Adm, San Francisco, CA, 94143
- NPI first listed
- 2006-08-30
- NPI last updated
- 2008-04-22
This is when the NPI record was last certified, not a medical board exam.